Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

73.62
-0.4900-0.66%
Post-market: 74.000.3800+0.52%19:30 EDT
Volume:1.44M
Turnover:106.88M
Market Cap:10.23B
PE:-10.25
High:75.10
Open:73.23
Low:73.13
Close:74.11
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.94
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-59.00
PE(LYR):-11.26

Loading ...

Cytokinetics Seen Gaining From Myqorzo Momentum to Treat Heart Conditions, UBS Says

MT Newswires Live
·
Jun 30

Cytokinetics Raised to Buy from Neutral by UBS

Dow Jones
·
Jun 30

Cytokinetics Inc : UBS Raises to Buy from Neutral

THOMSON REUTERS
·
Jun 29

UBS Upgrades Cytokinetics to Buy From Neutral, Adjusts Price Target to $115 From $69

MT Newswires Live
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Cytokinetics (CYTK)

TIPRANKS
·
Jun 29

S&P 500 Futures Drop in Premarket Trading; on Semiconductor, Davita Lag

Dow Jones
·
Jun 26

Cytokinetics Currently up Nine Days Straight, on Track for Longest Winning Streak Since March 2019

Dow Jones
·
Jun 25

Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 shares for $278,285‬

Reuters
·
Jun 24

Cytokinetics Inc : Mizuho Raises Target Price to $118 From $100

THOMSON REUTERS
·
Jun 23

Cytokinetics (CYTK) Stock Could Be 15% Undervalued After Myqorzo Approval

Simply Wall St.
·
Jun 19

Cytokinetics grants inducement equity awards to 12 new employees, sets options at $71.38

Reuters
·
Jun 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 18

Movement Alert|Cytokinetics Rises 5.17% in Regular Trading, Trading at $78.995

Market Focus
·
Jun 18

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and American Well (AMWL)

TIPRANKS
·
Jun 17

Cytokinetics Price Target Maintained With a $102.00/Share by Needham

Dow Jones
·
Jun 17

Cytokinetics: Competitive Overhang Eases After EDG-7500 Data, Analyst Reiterates Buy and $102 Price Target

TIPRANKS
·
Jun 17

S&P 500 Futures Rise In Premarket Trading; Western Digital, Agilent Technologies Lead

Dow Jones
·
Jun 16

Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $528,450

Reuters
·
Jun 16

Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares worth $237,930

Reuters
·
Jun 10